These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 10699689

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small-cell lung cancer?
    Hirose T, Okuda K, Yamaoka T, Ishida K, Kusumoto S, Sugiyama T, Shirai T, Ohnshi T, Ohmori T, Adachi M.
    Lung Cancer; 2011 Feb; 71(2):224-8. PubMed ID: 20537424
    [Abstract] [Full Text] [Related]

  • 3. Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC).
    Shibayama T, Ueoka H, Nishii K, Kiura K, Tabata M, Miyatake K, Kitajima T, Harada M.
    Lung Cancer; 2001 Apr; 32(1):61-9. PubMed ID: 11282430
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Serum levels of pro-gastrin-releasing peptide for follow-up of patients with small cell lung cancer.
    Okusaka T, Eguchi K, Kasai T, Kurata T, Yamamoto N, Ohe Y, Tamura T, Shinkai T, Saijo N.
    Clin Cancer Res; 1997 Jan; 3(1):123-7. PubMed ID: 9815547
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The diagnostic and prognostic value of ProGRP in lung cancer.
    Nisman B, Biran H, Ramu N, Heching N, Barak V, Peretz T.
    Anticancer Res; 2009 Nov; 29(11):4827-32. PubMed ID: 20032442
    [Abstract] [Full Text] [Related]

  • 12. [Utility of NSE, ProGRP and LDH in Diagnosis and Treatment
in Patients with Small Cell Lung Cancer].
    Peng Y, Wang Y, Li J, Hao X, Hu X.
    Zhongguo Fei Ai Za Zhi; 2016 Sep 20; 19(9):590-4. PubMed ID: 27666548
    [Abstract] [Full Text] [Related]

  • 13. Value of tumour and inflammatory markers in lung cancer.
    Oremek GM, Sauer-Eppel H, Bruzdziak TH.
    Anticancer Res; 2007 Sep 20; 27(4A):1911-5. PubMed ID: 17649794
    [Abstract] [Full Text] [Related]

  • 14. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
    Schneider J, Philipp M, Salewski L, Velcovsky HG.
    Clin Lab; 2003 Sep 20; 49(1-2):35-42. PubMed ID: 12593474
    [Abstract] [Full Text] [Related]

  • 15. [Tumor markers in lung cancer].
    Niho S, Shinkai T.
    Gan To Kagaku Ryoho; 2001 Dec 20; 28(13):2089-93. PubMed ID: 11791391
    [Abstract] [Full Text] [Related]

  • 16. Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer.
    Pujol JL, Quantin X, Jacot W, Boher JM, Grenier J, Lamy PJ.
    Lung Cancer; 2003 Feb 20; 39(2):131-8. PubMed ID: 12581564
    [Abstract] [Full Text] [Related]

  • 17. Comparison of neurone-specific enolase and pro-gastrin releasing peptide in the prognostic evaluation of small cell lung cancer patients.
    Satoh H, Kagohashi K, Kurishima K, Ishikawa H, Ohtsuka M.
    Clin Oncol (R Coll Radiol); 2006 Nov 20; 18(9):720. PubMed ID: 17100161
    [No Abstract] [Full Text] [Related]

  • 18. The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer.
    Nisman B, Heching N, Biran H, Barak V, Peretz T.
    Tumour Biol; 2006 Nov 20; 27(1):8-16. PubMed ID: 16340245
    [Abstract] [Full Text] [Related]

  • 19. [Clinical significance of ProGRP31-98 in patients with small-cell lung cancer].
    Yang J, Li R, Li A.
    Zhonghua Zhong Liu Za Zhi; 2000 May 20; 22(3):216-8. PubMed ID: 11778234
    [Abstract] [Full Text] [Related]

  • 20. [Immunohistochemical detection of carcinoembryonic antigen and P-glycoprotein in small cell lung cancer at diagnosis and relapse, with special reference to the tissue expression of CEA and response to chemotherapy].
    Ohnoshi T, Ueoka H, Segawa Y, Kiura K, Tabata M, Shibayama T, Maeda T, Miyatake K, Takigawa N, Kimura I.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Feb 20; 30(2):262-9. PubMed ID: 1351108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.